Page last updated: 2024-12-08
victoria blue 4r
Description
Victoria blue 4R: RN given refers to chloride [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
victoria blue 4R : An iminium salt composed of 4-([4-(dimethylamino)phenyl]{4-[methyl(phenyl)amino]naphthalen-1-yl}methylidene)-N,N-dimethylcyclohexa-2,5-dien-1-iminium and chloride ions in a 1:1 ratio. It binds to nucleic acids and can be used in standardised staining techniques suitable for automated cell-pattern recognition. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
ID Source | ID |
PubMed CID | 160620 |
CHEBI ID | 87643 |
SCHEMBL ID | 1812816 |
MeSH ID | M0066002 |
Synonyms (21)
Synonym |
victoria basic blue f4r |
victoria blue f 4r |
nsc11248 |
2185-87-7 |
nsc-11248 |
c.i. basic blue 8 |
victoria blue 4r |
(4-((4-(dimethylamino)phenyl)(4-toluidino-1-naphthyl)methylene)cyclohexa-2,5-dien-1-ylidene)dimethylammonium chloride |
n-(4-((4-(dimethylamino)phenyl)(4-(methylphenylamino)-1-naphthalenyl)methylene)-2,5-cyclohexadi en-1-ylidene)-n-methylmethanaminium chloride |
einecs 218-573-2 |
methanaminium, n-(4-((4-(dimethylamino)phenyl)(4-(methylphenylamino)-1-naphthalenyl)methylene)-2,5-cyclohexadien-1-ylidene)-n-methyl-, chloride |
nsc 11248 |
SCHEMBL1812816 |
basic blue 8 |
4-([4-(dimethylamino)phenyl]{4-[methyl(phenyl)amino]naphthalen-1-yl}methylidene)-n,n-dimethylcyclohexa-2,5-dien-1-iminium chloride |
c.i. 42563 |
CHEBI:87643 |
Q27159797 |
DTXSID80944453 |
[4-[bis[4-(dimethylamino)phenyl]methylidene]naphthalen-1-ylidene]-methyl-phenylazanium;chloride |
n-(4-((4-(dimethylamino)phenyl)(4-(methyl(phenyl)amino)naphthalen-1-yl)methylene)cyclohexa-2,5-dien-1-ylidene)-n-methylmethanaminium chloride |
Roles (2)
Role | Description |
histological dye | A dye used in microscopic or electron microscopic examination of cells and tissues to give contrast and to highlight particular features of interest, such as nuclei and cytoplasm. |
fluorochrome | A fluorescent dye used to stain biological specimens. |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Drug Classes (2)
Class | Description |
organic chloride salt | |
iminium salt | Salts in which the cation has the structure R2C=N(+)R2. Thus N-hydronated imines and their N-substituted derivatives. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (7)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 5 (71.43) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 17.43
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 17.43 (24.57) | Research Supply Index | 2.08 (2.92) | Research Growth Index | 4.32 (4.65) | Search Engine Demand Index | 10.37 (26.88) | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |